At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
ZLAB Zai Lab Ltd
Trading 02-26 12:28:16 EST
19.86
+0.47
+2.40%
High19.96Low18.63Vol161.33K
Open18.80D1 Closing19.39Amplitude6.86%
Mkt Cap2.20BTradable Cap2.17BTotal Shares111.00M
T/O3.14MT/O Rate0.15%Tradable Shares109.37M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

Zai Lab Reports 15% Revenue Growth to $460.2 Million for 2025, Highlights Major Pipeline Progress
Stock News  ·  02-26 21:09
Zai Lab Reports 15% Revenue Growth to $460.2 Million for 2025, Highlights Major Pipeline Progress
Zai Lab Q4 EPS $0.46 Beats $(0.05) Estimate, Sales $127.597M Beat $124.472M Estimate
Benzinga  ·  02-26 20:08
Zai Lab Q4 EPS $0.46 Beats $(0.05) Estimate, Sales $127.597M Beat $124.472M Estimate
Press Release: Zai Lab Announces Fourth Quarter and Full Year 2025 Financial Results and Recent Corporate Updates
Dow Jones  ·  02-26 20:00
Press Release: Zai Lab Announces Fourth Quarter and Full Year 2025 Financial Results and Recent Corporate Updates
Zai Lab Reports Positive Phase 3 ADAPT OCULUS Results for VYVGART in Ocular Myasthenia Gravis
Reuters  ·  02-26 14:27
Zai Lab Reports Positive Phase 3 ADAPT OCULUS Results for VYVGART in Ocular Myasthenia Gravis
Zai Lab price target lowered to $53 from $58 at Citi
TIPRANKS  ·  02-20
Zai Lab price target lowered to $53 from $58 at Citi
Zai Lab Ltd : Citigroup Cuts Target Price to $53 From $58
THOMSON REUTERS  ·  02-20
Zai Lab Ltd : Citigroup Cuts Target Price to $53 From $58
Earning Preview: Zai Lab Ltd this quarter’s revenue is expected to increase by 11.75%, and institutional views are mostly bullish
Earnings Agent  ·  02-19
Earning Preview: Zai Lab Ltd this quarter’s revenue is expected to increase by 11.75%, and institutional views are mostly bullish
Asian Equities Traded in the US as American Depositary Receipts Advance in Friday Trading
MT Newswires Live  ·  02-13
Asian Equities Traded in the US as American Depositary Receipts Advance in Friday Trading
Zai Lab Shares Extend Gains, Rising Over 5% on Potential Breakthrough Therapy Designation for ZL-1310
Stock News  ·  02-13
Zai Lab Shares Extend Gains, Rising Over 5% on Potential Breakthrough Therapy Designation for ZL-1310
Press Release: Zai Lab to Announce Fourth Quarter and Full Year 2025 Financial Results and Recent Corporate Updates on February 26, 2026
Dow Jones  ·  02-10
Press Release: Zai Lab to Announce Fourth Quarter and Full Year 2025 Financial Results and Recent Corporate Updates on February 26, 2026
Bernstein Keeps Their Hold Rating on Zai Lab Ltd (1ZLB)
TIPRANKS  ·  02-10
Bernstein Keeps Their Hold Rating on Zai Lab Ltd (1ZLB)
Zai Lab price target lowered to $39 from $46 at JPMorgan
TIPRANKS  ·  02-05
Zai Lab price target lowered to $39 from $46 at JPMorgan
JPMorgan Chase Increases Stake in Zai Lab by Approximately 1.92 Million Shares at HK$13.34 Per Share
Stock News  ·  02-04
JPMorgan Chase Increases Stake in Zai Lab by Approximately 1.92 Million Shares at HK$13.34 Per Share
SPDB Reaffirms Their Buy Rating on Zai Lab Ltd (1ZLB)
TIPRANKS  ·  02-03
SPDB Reaffirms Their Buy Rating on Zai Lab Ltd (1ZLB)
A Look At Zai Lab (NasdaqGM:ZLAB) Valuation As UBS Initiates Coverage And Highlights Global Pipeline Shift
Simply Wall St.  ·  02-02
A Look At Zai Lab (NasdaqGM:ZLAB) Valuation As UBS Initiates Coverage And Highlights Global Pipeline Shift
Zai Lab Ltd (1ZLB) Gets a Buy from Guotai Haitong
TIPRANKS  ·  01-30
Zai Lab Ltd (1ZLB) Gets a Buy from Guotai Haitong
Haitong International Maintains "Outperform" Rating on Zai Lab (09688), Sees Dual Engines Driving Long-Term Global Value
Stock News  ·  01-30
Haitong International Maintains "Outperform" Rating on Zai Lab (09688), Sees Dual Engines Driving Long-Term Global Value
Citi Keeps Their Buy Rating on Zai Lab (ZLAB)
TIPRANKS  ·  01-15
Citi Keeps Their Buy Rating on Zai Lab (ZLAB)
Zhutong Hong Kong Stock Morning Briefing | Ministry of Finance Holds Meeting on Fiscal-Financial Synergy to Boost Domestic Demand; White House Announces 25% Tariff Hike on Specific Semiconductors
Stock News  ·  01-15
Zhutong Hong Kong Stock Morning Briefing | Ministry of Finance Holds Meeting on Fiscal-Financial Synergy to Boost Domestic Demand; White House Announces 25% Tariff Hike on Specific Semiconductors
Zai Lab Rises Over 7% in Morning Session Following Appearance at JPMorgan Healthcare Conference
Deep News  ·  01-14
Zai Lab Rises Over 7% in Morning Session Following Appearance at JPMorgan Healthcare Conference

Introduction

Company Name.
Zai Lab Ltd
Affiliated Markets:
NASDAQ
Listing Date:
--
Main Business:
Zai Lab Ltd is a holding company primarily engaged in biopharmaceutical business. The Company is focused on discovering, developing, and commercializing products that address medical conditions with significant unmet needs in the areas of oncology, immunology, neuroscience, and infectious disease. The Company has a series of patented drug candidates from the discovery stage to the late clinical project, including ZEJULA, OPTUNE, QINLOCK, NUZYRA and VYVGART, and others. The Company conducts its businesses within domestic and overseas markets.
Issue price:
--